Sign in

CIK 0002044950

Bambusa Therapeutics, Inc.

Sign in to watch
Ticker
BBTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
other
EIN
992083913
Phone
(617) 848-6188
Business address
22 BOSTON WHARF ROAD, FLOOR 7, BOSTON, MA
  1. 4 Open-market buy Director bought 2,953,820 shares at an average $15.79 ($46,639,957)
  2. 4 Open-market buy 10% owner bought 375,000 shares at $16.00 ($6,000,000)
  3. 4 Open-market buy Director bought 375,000 shares at $16.00 ($6,000,000)
  4. 4 Conversion See remarks acquired 163,596 shares (conversion)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership

Page 1 of 1 · 14 filings